Premium
The influence of antineoplastic chemotherapy on the glutathione enzymes activity in the blood
Author(s) -
Kopañski Z.,
Grabowska M.,
KosiniakKamysz A.,
Bertrandt J.,
Kołodziejski L.,
Opoka W.,
SchlegelZawadzka M.
Publication year - 2004
Publication title -
biofactors
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.204
H-Index - 94
eISSN - 1872-8081
pISSN - 0951-6433
DOI - 10.1002/biof.5520220115
Subject(s) - chemotherapy , glutathione peroxidase , cisplatin , glutathione reductase , glutathione , doxorubicin , enzyme , pharmacology , medicine , antioxidant , oncology , chemistry , biochemistry
The analysis included 78 patients (42 men and 36 women) aged 48 to 67 years treated with cytostatics because of a neoplastic disease. In all the patients examined was evaluated the influence of the chemotherapy carried out on the glutathione peroxidase (GPx) and glutathione reductase (GR) activities. It was confirmed that the effect of the action on the glutathione enzymes (GE) activity of the antineoplastic chemotherapy changes depending on the duration of the treatment with cytostatics. In the end this activity settles at a high level, statistically significantly higher than that registered before the beginning of the antineoplastic treatment. The increase of the GE activity is mainly favoured by the chemotherapy following the schemes FAC (5‐fluorouracyl + doxorubicin + endoxan) and PAC (cisplatin + cyclofosfamide + pharmorubicin).